Pharmaceutical Executive October 28, 2024
Miranda Schmalfuhs

The latest news for pharma industry insiders.

Operating Without a Commercial Blueprint: Empowering the Field for Niche Therapy Launches

How emerging biotech companies can create fruitful partnerships between home office commercial teams and the field force to enable this intelligence gathering, while driving commercial success.

The Dilemma of Childhood Vaccines Post Pandemic

With the end of the PREP Act Provisions in sight, pharmacists should Reflect on their impact and plan to continue them.

Government ‘Guardrails’ for A.I. Tools

A national security memorandum detailed how agencies should streamline operations with artificial intelligence safely.

President Biden has released a series of documents that grapple with the challenges of using A.I. tools to speed up government operations.

LabGenomics USA Completes Acquisition of IMD...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Bariatric Surgeons Being Put Out of Work by GLP-1 Drugs
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Mark Cuban's 2025 plans
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025

Share This Article